Upgrade to SI Premium - Free Trial

H.C. Wainwright Upgrades Trillium Therapeutics (TRIL) to Buy

September 10, 2020 6:14 AM
H.C. Wainwright analyst Swayampakula Ramakanth upgraded Trillium Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Upgrades

Next Articles